DUSP6
Dual specificity protein phosphatase 6
Also known as: DUS6_HUMAN, MKP-3, PYST1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16828
- Gene
- DUSP6
- Ensembl
- ENSG00000139318
- Chromosome
- 12
- Canonical length
- 381 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK2, is expressed in a variety of tissues with the highest levels in heart and pancreas, and unlike most other members of this family, is localized in the cytoplasm. Mutations in this gene have been associated with congenital hypogonadotropic hypogonadism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>Q16828|DUSP6
1 MIDTLRPVPF ASEMAISKTV AWLNEQLELG NERLLLMDCR PQELYESSHI ESAINVAIPG
61 IMLRRLQKGN LPVRALFTRG EDRDRFTRRC GTDTVVLYDE SSSDWNENTG GESVLGLLLK
121 KLKDEGCRAF YLEGGFSKFQ AEFSLHCETN LDGSCSSSSP PLPVLGLGGL RISSDSSSDI
181 ESDLDRDPNS ATDSDGSPLS NSQPSFPVEI LPFLYLGCAK DSTNLDVLEE FGIKYILNVT
241 PNLPNLFENA GEFKYKQIPI SDHWSQNLSQ FFPEAISFID EARGKNCGVL VHCLAGISRS
301 VTVTVAYLMQ KLNLSMNDAY DIVKMKKSNI SPNFNFMGQL LDFERTLGLS SPCDNRVPAQ
361 QLYFTTPSNQ NVYQVDSLQS TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 213 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 213 nTPM
- bone marrow: 169 nTPM
- liver: 134 nTPM
- adipose tissue: 107 nTPM
- lung: 83 nTPM
- thyroid gland: 72 nTPM
Single-cell type
- retinal pigment epithelial cells: 392 nCPM
- alveolar cells type 2: 384 nCPM
- monocytes: 380 nCPM
- medullary thymic epithelial cells: 350 nCPM
- mast cells: 285 nCPM
- neutrophil progenitors: 263 nCPM
Immune cell
- basophil: 1,643 nTPM
- non-classical monocyte: 846 nTPM
- intermediate monocyte: 844 nTPM
- classical monocyte: 560 nTPM
- total PBMC: 456 nTPM
- eosinophil: 248 nTPM
Brain region
- choroid plexus: 56 nTPM
- cerebral cortex: 53 nTPM
- hippocampal formation: 35 nTPM
- thalamus: 28 nTPM
- white matter: 22 nTPM
- spinal cord: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DUSP6.
Disease | AllUniProt
Conditions DUSP6 is implicated in, by any mechanism.
- Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) MIM:615269
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 100 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypogonadotropic hypogonadism 19 with or without anosmia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.22
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- ERK1 and ERK2 cascade
- MAPK cascade
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of MAPK cascade
- peptidyl-tyrosine dephosphorylation
- positive regulation of apoptotic process
- regulation of heart growth
- response to growth factor
- response to nitrosative stress
- response to xenobiotic stimulus
- signal transduction
Molecular functions
- MAP kinase tyrosine phosphatase activity
- MAP kinase tyrosine/serine/threonine phosphatase activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
- protein tyrosine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Rhodanese-like domain
- Mitogen-activated protein (MAP) kinase phosphatase
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Rhodanese-like domain superfamily
- Rhodanese-like domain
- Dual specificity phosphatase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DUSP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP6 as an antibody target. Whether an autoantibody or antibody against DUSP6 could matter depends on whether native DUSP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...